Canada markets closed

PsyBio Therapeutics Corp. (PSYBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1738-0.0011 (-0.62%)
At close: 03:51PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 21.43M
Enterprise Value 15.14M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-42.35%
S&P500 52-Week Change 322.74%
52 Week High 30.7900
52 Week Low 30.1527
50-Day Moving Average 30.2307
200-Day Moving Average 30.2901

Share Statistics

Avg Vol (3 month) 376.45k
Avg Vol (10 day) 385.78k
Shares Outstanding 561.39M
Implied Shares Outstanding 6112.96M
Float 8112.47M
% Held by Insiders 11.09%
% Held by Institutions 10.38%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3Oct. 17, 2016
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-1.53M
EBITDA N/A
Net Income Avi to Common (ttm)-12.47M
Diluted EPS (ttm)-0.0880
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.96M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.18
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-6.52M
Levered Free Cash Flow (ttm)N/A